| Fred S Herzon, MD | |
|
1101 Madison St, Suite 301, Seattle, WA 98104-1306 | |
| (206) 505-1101 | |
| (206) 505-1041 |
| Full Name | Fred S Herzon |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 1101 Madison St, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558346072 | NPI | - | NPPES |
| 8438384 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD00042135 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fred S Herzon, MD 1101 Madison St, Suite 301, Seattle, WA 98104-1306 Ph: (206) 505-1101 | Fred S Herzon, MD 1101 Madison St, Suite 301, Seattle, WA 98104-1306 Ph: (206) 505-1101 |
News Archive
Worried that dust from a nearby construction zone will harm your family's health? A new Tel Aviv University tool could either confirm your suspicions or better yet, set your mind at rest.
Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced that the World Health Organization ("WHO") on Sunday July 17, 2011 warned that the widely used blood tests to detect tuberculosis ("TB") are unreliable and "dangerous" to patients because they produce too many false negatives and positives.
Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.
A new, reversible antiplatelet drug did not demonstrate superiority over a current irreversible one in reducing the composite of death, heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
› Verified 9 days ago
Judith A White, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1600 E Jefferson St, Suite 205, Seattle, WA 98122 Phone: 206-320-3900 Fax: 206-320-3899 | |
Kathleen Makielski, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 904 7th Ave, Seattle, WA 98104 Phone: 206-329-1760 | |
David Louis Horn, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Mailstop W-7729, Seattle, WA 98105 Phone: 206-987-2105 Fax: 206-987-3878 | |
Amit D Bhrany, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Bb1165, Box 356515, Seattle, WA 98195 Phone: 206-543-5230 Fax: 206-543-5152 | |
Gabriela Sanchez, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 200, Seattle, WA 98122 Phone: 206-215-6009 Fax: 206-215-1771 | |
Sapna Ashok Patel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 280, Seattle, WA 98122 Phone: 206-386-3550 Fax: 206-386-3550 | |
John P Rowland, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |